anmelden
SPI Financial Services
1.804,56
PKT
+0,27
PKT
+0,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Financial Services-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.10.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 24.10.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 23.10.12 | Swiss Re neutral | Credit Suisse Group | |
| 23.10.12 | UBS hold | Commerzbank Corp. & Markets | |
| 23.10.12 | GAM hold | Vontobel Research | |
| 23.10.12 | UBS underperform | Cheuvreux SA | |
| 23.10.12 | UBS hold | Commerzbank Corp. & Markets | |
| 22.10.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 22.10.12 | EFG International neutral | Sarasin Research | |
| 22.10.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 22.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 19.10.12 | Zurich Insurance neutral | Sarasin Research | |
| 19.10.12 | Zurich Insurance hold | Deutsche Bank AG | |
| 19.10.12 | Swiss Re neutral | Sarasin Research | |
| 19.10.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 19.10.12 | Swiss Re buy | Vontobel Research | |
| 18.10.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 18.10.12 | UBS overweight | Morgan Stanley | |
| 18.10.12 | UBS equal-weight | Morgan Stanley | |
| 18.10.12 | Julius Bär equal-weight | Morgan Stanley | |
| 18.10.12 | Swiss Life buy | Nomura | |
| 18.10.12 | UBS buy | Deutsche Bank AG | |
| 18.10.12 | UBS hold | Deutsche Bank AG | |
| 18.10.12 | Zurich Insurance hold | Société Générale Group S.A. (SG) | |
| 18.10.12 | Zurich Insurance outperform | Keefe, Bruyette & Woods, Inc. | |
| 17.10.12 | Zurich Insurance halten | Independent Research GmbH | |
| 17.10.12 | Zurich Insurance neutral | Sarasin Research | |
| 17.10.12 | Zurich Insurance hold | Vontobel Research | |
| 16.10.12 | UBS neutral | Macquarie Research | |
| 15.10.12 | UBS outperform | Exane-BNP Paribas SA | |
| 15.10.12 | UBS neutral | Exane-BNP Paribas SA | |
| 15.10.12 | Swiss Life neutral | Goldman Sachs Group Inc. | |
| 12.10.12 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 12.10.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 12.10.12 | UBS outperform | Credit Suisse Group | |
| 12.10.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 10.10.12 | UBS overweight | J.P. Morgan Cazenove | |
| 10.10.12 | Julius Bär buy | Nomura | |
| 09.10.12 | Julius Bär buy | Sarasin Research | |
| 08.10.12 | Swiss Re overweight | J.P. Morgan Cazenove |